The crystallographic studies revealed that the existence of the strong non-bonding interactions facilitate these molecules to interact with biological macro-molecules like DNA that described to inherit good biological activities.
These results demonstrate that a purified soluble form of the C-terminus of peripherin/rds can interact with biological phospholipids; moreover, this interaction promotes a conformational change that is most consistent with an increase in α-helical content.
The neutral amino acids can promote hydrogen bonding with the mucosa, while the lipophilic residues can interact with biological tissues via hydrophobic interactions.
To tailor these interactions, a comprehensive knowledge of how nanomaterials interact with biological systems is critical.
This finding is highly significant for many applications where nanostructures interact with biological systems, for the understanding of cell-nanostructured surface interaction and for the general understanding of the nano-bio interface.
"Because of their small size, engineered nanomaterials have unique properties that do not exist at the larger scale: increased surface area, charge, reactivity and other physicochemical properties, all of which may affect how nanomaterials interact with biological entities, like cells," says Sara Brenner, assistant professor of nanobioscience at SUNY Polytechnic Institute.
First, pharmaceuticals are carefully designed to interact with biological processes.
Biomaterials interact with biological tissue through their surfaces.
Notably, external factors interact with biological properties, yielding the superimposition of both impacts in the population.
Chemical entities that specifically interact with biological molecules can reveal the biological role of their targets.
In biomedical fields, nanomaterials are of the appropriate dimensions to interact with biological matter.
